Comment Interesting development (Score 2) 21
The drug under discussion here, bretisilocin, appears to be an improved serotonergic psychadelic. Compared to DMT and psilocyn (magic mushrooms), bretisilocon substitutes an ethyl group for one of the methyls attached to the amine end. This adds one carbon (and 2H), extending the molecule and altering its binding to receptors. My educated guess is that this means more psychedelic specificity and perhaps less drowsyness. Bretisilocin also has a fluorine at position 5 of the indole ring: fluorine is included in something like half of new drugs and affects stability and solubility (and perhaps patentability). Whether or not this explains the 60-90 minute active lifetime of the drug, this lifetime is convenient in a clinical setting where the 3-4 hour magic mushroom experience raises the costs considerably and the 10-15 minute DMT trip may me insufficient for theraputic breakthrough.
I'd also like to mention safety and efficacy from the perspective of an interested observer. These drugs tend to be ridiculously safe from a physical perspective, and the psychological risks have been largely overstated. That said, drugs have side effects and these will be noted as this goes through clinical trials. What these drugs do offer is
Lastly, psychedelics are used for spiritual/religious purposes, medical treatment, and for curiosity/recreation. I'm getting old enough to be comfortable saying that I support all of these when used with sincerity, However, I don't believe anyone finds truth in the substances, just a opening of some mental space to grow. Or not, if that's what you prefer.